Aristotle Atlantic Partners, LLC Bristol Myers Squibb CO Transaction History

Aristotle Atlantic Partners, LLC

$3.08 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $317,873 - $355,432	-5,491 Reduced 2.37%	226,267 $13.1 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $3.63 Million - $4.03 Million	57,033 Added 32.64%	231,758 $14.8 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $64,461 - $73,113	981 Added 0.56%	174,725 $12.1 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $45,813 - $54,249	669 Added 0.39%	173,744 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $166 - $98,432	1,281 Added 0.75%	173,075 $12.3 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $2.45 Million - $2.69 Million	33,684 Added 24.39%	171,794 $13.2 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $226,246 - $271,289	3,680 Added 2.74%	138,110 $10.1 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.7 Million - $1.98 Million	-31,655 Reduced 19.06%	134,430 $8.38 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $138,221 - $161,908	2,336 Added 1.43%	166,085 $9.83 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $201,640 - $219,586	3,257 Added 2.03%	163,749 $10.9 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $1.93 Million - $2.17 Million	32,559 Added 25.45%	160,492 $10.1 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $55,661 - $63,074	964 Added 0.76%	127,933 $7.94 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $57,774 - $64,021	1,006 Added 0.8%	126,969 $7.66 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $187,429 - $219,123	3,419 Added 2.79%	125,963 $7.41 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $35,264 - $51,246	760 Added 0.62%	122,544 $6.83 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $5.99 Million - $7.82 Million	121,784 New	121,784 $7.82 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $175,536 - $227,628	-3,600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $198,684 - $224,100	3,600 New	3,600 $223,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $181,908 - $226,728	-3,600 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $215,784 - $235,259	3,600	3,600 $221,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.

Account